UPDATED GlaxoSmithKline (GSK) has told us it is having problems with the supply of Lamictal. This is due to manufacturing problems.
Update as of 20 March 2017:
GSK is still having problems with supply of Lamictal. The following doses are currently out of stock:
- 2 mg CD (chewable dispersible) tablets
- 25 mg dispersible tablets
- 50 mg tablets
- 100 mg tablets
GSK expects these to be back in stock in early April.
All other doses of Lamictal are currently in stock.
Update as of February 8 2017:
50 mg tablets are back in stock.
100 mg tablets are now out of stock. GSK are due to get some stock in this week, and expect to be back to full stock levels in the week commencing 13th March.
50 mg tablets: low in stock. The current stock is due to last until the end of January. GSK don’t know when they will be back in stock.
100 mg tablets: low in stock. GSK expects stock to be back to normal on 6 February.
200 mg tablets: stock levels are normal.
When we get an update on this situation we will update this page.
If you have any concerns about this please speak to your doctor or epilepsy nurse.